Literature DB >> 27343882

The Bipolar Prodrome: Meta-Analysis of Symptom Prevalence Prior to Initial or Recurrent Mood Episodes.

Anna R Van Meter1, Coty Burke2, Eric A Youngstrom2, Gianni L Faedda3, Christoph U Correll4.   

Abstract

OBJECTIVE: The aim of this study was to meta-analyze the prevalence of symptoms before an initial mood episode of bipolar disorder (BD) and the prevalence of subthreshold symptoms before a BD mood episode recurrence, to facilitate early identification and prevention.
METHOD: Systematic literature reviews were conducted in PsycINFO and PubMed for prospective or retrospective studies reporting on the prevalence and longest duration of symptoms before an initial or recurrent mood episode of BD. Random effects meta-regression explored whether geographic location, age, percentage of female individuals, and study quality moderated the overall prevalence.
RESULTS: In 11 studies (n = 1,078), the prodrome preceding an initial mood episode lasted 27.1 ± 23.1 months (range, 4.6-130 months). In 10 studies (n = 1,000), the subthreshold symptoms preceding a recurrent mood episode lasted 1.0 ± 0.9 months (range, 0.5-1.3 months). The most common symptoms were largely consistent with diagnostic criteria symptoms associated with the subsequent mood polarity for both the initial prodrome and the period prior to a recurrent mood episode. Few moderators of symptom prevalences emerged, and significant heterogeneity remained.
CONCLUSION: The initial prodromal period is sufficiently long and characterized by symptoms of the subsequent mood episode to make early identification and intervention programs feasible. Conversely, the period of subthreshold symptoms before a recurrent mood episode is short, mandating adequate psychoeducation of patients and families, monitoring of changes in sleep and activity, plus sufficiently frequent follow-up visits to identify patients before a mood episode recurrence. Future prospective investigations, designed to address the identified shortcomings in the extant literature, are needed to identify more clinically applicable information.
Copyright © 2016 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bipolar disorder; early identification; first episode; prodrome; subthreshold

Mesh:

Year:  2016        PMID: 27343882     DOI: 10.1016/j.jaac.2016.04.017

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  39 in total

1.  A Pharmacologic Algorithm for Youth Who Are at High Risk for Bipolar Disorder.

Authors:  Christopher D Schneck; Kiki D Chang; Manpreet K Singh; Melissa P DelBello; David J Miklowitz
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-07-21       Impact factor: 2.576

2.  Structural Brain Alterations in Youth With Psychosis and Bipolar Spectrum Symptoms.

Authors:  Maria Jalbrzikowski; David Freedman; Catherine E Hegarty; Eva Mennigen; Katherine H Karlsgodt; Loes M Olde Loohuis; Roel A Ophoff; Raquel E Gur; Carrie E Bearden
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-01-18       Impact factor: 8.829

3.  Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.

Authors:  Lorenzo Pelizza; Silvia Azzali; Sara Garlassi; Federica Paterlini; Ilaria Scazza; Luigi Rocco Chiri; Simona Pupo; Andrea Raballo
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-10-20       Impact factor: 4.785

4.  Intrinsic functional connectivity correlates of person-level risk for bipolar disorder in offspring of affected parents.

Authors:  Danella M Hafeman; Henry W Chase; Kelly Monk; Lisa Bonar; Mary Beth Hickey; Alicia McCaffrey; Simona Graur; Anna Manelis; Cecile D Ladouceur; John Merranko; David A Axelson; Benjamin I Goldstein; Tina R Goldstein; Boris Birmaher; Mary L Phillips
Journal:  Neuropsychopharmacology       Date:  2018-11-08       Impact factor: 7.853

5.  Longitudinal course and characteristics of cyclothymic disorder in youth.

Authors:  Anna R Van Meter; Eric A Youngstrom; Boris Birmaher; Mary A Fristad; Sarah M Horwitz; Thomas W Frazier; L Eugene Arnold; Robert L Findling
Journal:  J Affect Disord       Date:  2017-03-14       Impact factor: 4.839

6.  Severity and Variability of Depression Symptoms Predicting Suicide Attempt in High-Risk Individuals.

Authors:  Nadine M Melhem; Giovanna Porta; Maria A Oquendo; Jamie Zelazny; John G Keilp; Satish Iyengar; Ainsley Burke; Boris Birmaher; Barbara Stanley; J John Mann; David A Brent
Journal:  JAMA Psychiatry       Date:  2019-06-01       Impact factor: 21.596

7.  Characteristics of youth at high risk for bipolar disorder compared to youth with bipolar I or II disorder.

Authors:  Marc J Weintraub; Christopher D Schneck; Patricia D Walshaw; Kiki D Chang; Manpreet K Singh; David A Axelson; Boris Birmaher; David J Miklowitz
Journal:  J Psychiatr Res       Date:  2020-01-25       Impact factor: 4.791

8.  A Risk Calculator to Predict the Individual Risk of Conversion From Subthreshold Bipolar Symptoms to Bipolar Disorder I or II in Youth.

Authors:  Boris Birmaher; John A Merranko; Tina R Goldstein; Mary Kay Gill; Benjamin I Goldstein; Heather Hower; Shirley Yen; Danella Hafeman; Michael Strober; Rasim S Diler; David Axelson; Neal D Ryan; Martin B Keller
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-08-07       Impact factor: 8.829

9.  Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects.

Authors:  Marco Solmi; Michele Fornaro; Edoardo G Ostinelli; Caroline Zangani; Giovanni Croatto; Francesco Monaco; Damir Krinitski; Paolo Fusar-Poli; Christoph U Correll
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

Review 10.  A Review on the General Stability of Mood Disorder Diagnoses Along the Lifetime.

Authors:  Diego de la Vega; Ana Piña; Francisco J Peralta; Sam A Kelly; Lucas Giner
Journal:  Curr Psychiatry Rep       Date:  2018-04-02       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.